Akums Drugs and Pharmaceuticals Ltd’s shares listed at Rs 725, marking a 6.77% premium over the issue price of Rs 679, and later soared 15.55% to Rs 784.65 on the BSE. The company’s market valuation hit Rs 11,806.91 crore in early trade. The IPO, priced between Rs 646-679, was heavily oversubscribed, receiving 63.56 times subscription. Funds will be used for debt repayment, working capital, acquisitions, and general purposes. For investors, the strong debut reflects high demand and positive market sentiment toward the company’s growth prospects.
